|
FRK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10570441691493E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69679825745561E-11 |
| Normal-vs-Stage2 |
2.20429999997496E-06 |
| Normal-vs-Stage3 |
6.27799999763923E-08 |
| Normal-vs-Stage4 |
1.04619999996558E-07 |
| Stage1-vs-Stage2 |
8.751600E-01 |
| Stage1-vs-Stage3 |
8.453600E-01 |
| Stage1-vs-Stage4 |
2.927400E-01 |
| Stage2-vs-Stage3 |
9.928600E-01 |
| Stage2-vs-Stage4 |
3.821600E-01 |
| Stage3-vs-Stage4 |
3.920200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.80542297462716E-12 |
| Normal-vs-AfricanAmerican |
2.08829997738746E-09 |
| Normal-vs-Asian |
2.38439999999951E-06 |
| Caucasian-vs-AfricanAmerican |
9.668600E-01 |
| Caucasian-vs-Asian |
3.668600E-01 |
| AfricanAmerican-vs-Asian |
1.299370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62769797640294E-12 |
| Normal-vs-Female |
6.55360000045846E-07 |
| Male-vs-Female |
3.204200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.22599999999407E-06 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.58189999988068E-08 |
| Normal-vs-Extreme_Obese |
2.05709999999693E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.089580E-01 |
| Normal_Weight-vs-Obese |
8.756200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.719800E-01 |
| Extreme_Weight-vs-Obese |
1.585630E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.179000E-01 |
| Obese-vs-Extreme_Obese |
7.633200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.62810000001879E-07 |
| Normal-vs-Age(41-60Yrs) |
7.5742967453607E-11 |
| Normal-vs-Age(61-80Yrs) |
3.26860760679892E-12 |
| Normal-vs-Age(81-100Yrs) |
2.22249999959345E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.439000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.934000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.216400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.520800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.125600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.999200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
7.54520000034731E-07 |
| Normal-VS-KIRP CIMP |
1.504880E-03 |
| Normal-VS-Unclassified PRCC |
3.81910000002428E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.738200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.436560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.664170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.758400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.596200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.630200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.9235281690253E-12 |
| Normal-vs-N1 |
2.98530000053532E-07 |
| Normal-vs-N2 |
6.26229999999284E-05 |
| N0-vs-N1 |
3.457200E-01 |
| N0-vs-N2 |
5.552800E-01 |
| N1-vs-N2 |
3.424800E-01 |
|
|
